1615876

Sorafenib Tosylate

United States Pharmacopeia (USP) Reference Standard

• 别名: 4-[4-[[4-Chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide, 4-methylbenzenesulfonic acid
• 经验公式（希尔记法）: C₂₁H₁₆ClF₃N₄O₃·C₇H₈SO₃
• CAS号: 475207-59-1
• 分子量: 637.03
• 分類程式碼代碼: 41116107
• NACRES: NA.24

属性

• API 家族: sorafenib
• 製造商／商標名: USP
• 應用: pharmaceutical (small molecule)
• 格式: neat
• 儲存溫度: −20°C
• InChI: 1S/C21H16ClF3N4O3.C7H8O3S/c1-26-19(30)18-11-15(8-9-27-18)32-14-5-2-12(3-6-14)28-20(31)29-13-4-7-17(22)16(10-13)21(23,24)25;1-6-2-4-7(5-3-6)11(8,9)10/h2-11H,1H3,(H,26,30)(H2,28,29,31);2-5H,1H3,(H,8,9,10)
• InChI 密鑰: IVDHYUQIDRJSTI-UHFFFAOYSA-N

说明

一般說明

This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.

應用

Sorafenib Tosylate USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:

• Regorafenib
• Sorafenib Tablets
• Sorafenib Tosylate

分析報告

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  

其他說明

Sales restrictions may apply.

安全信息

• 象形圖: GHS08,GHS09
• 訊號詞: Danger
• 危險聲明: H360FD,H362,H372,H410
• 防範說明: P202 - P260 - P263 - P264 - P273 - P308 + P313
• 危險分類: Aquatic Acute 1 - Aquatic Chronic 1 - Lact. - Repr. 1B - STOT RE 1
• 儲存類別代碼: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• 水污染物質分類（WGK）: WGK 3
• 閃點（°F）: Not applicable
• 閃點（°C）: Not applicable